Streaming Titan Stumbles on Slower Signups, Slumps 8%

Author

Adam Garcia
April 29, 2025

A global beverage giant beat revenue forecasts with a mix of price hikes and steady demand, a pharma heavyweight topped profit estimates, and a major streaming platform is sliding after missing user growth targets. Here’s what you need to know.

Energy Sector Watch (Sponsored)

On Behalf of Azincourt Energy Corp

Uranium has doubled since 2020.

Saskatchewan’s uranium sales just hit $2.6 billion, up 62% year-over-year.

Now layer on the global demand curve:

  • 30+ countries pledging to triple nuclear capacity

  • AI data centers expected to use 12% of US electricity by 2028

  • Germany reversing course and returning to nuclear

The setup is here.

And one company has plans to drill in the heart of it all: Canada’s Athabasca Basin.

With early uranium hits, expanding alteration zones, and proximity to NexGen and Cameco, this could be the next name to watch in the sector.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Futures 📈

What to Watch

Earnings:

  • Visa Inc. [V]: Aftermarket

  • Booking Holdings Inc. [BKNG]: Aftermarket

  • Starbucks Corporation [SBUX]: Aftermarket

Economic Reports:

  • Advanced U.S. Trade Balance in Goods [March]: 8:30 am

  • Advanced Retail Inventories [March]: 8:30 am

  • Advanced Wholesale Inventories [March]: 8:30 am

  • S&P Case-Shiller Home Price Index (20 Cities) [February]: 9:00 am

  • Consumer Confidence [April]: 10:00 am

  • Job Openings [March]: 10:00 am

Future of Global Energy (Sponsored)

On Behalf of Azincourt Energy Corp

When Peter Thiel joins the board of a uranium enrichment startup and backs a $50 million raise, you pay attention.

Because this isn’t just Thiel.

It’s Gates with TerraPower. Bezos with General Fusion. Altman with Oklo. And now Thiel with General Matter.

The smartest minds of this generation are placing billion-dollar bets on one thing: Nuclear.

And it’s not hard to see why.

Global electricity demand is set to soar 50% by 2050.

AI. Data centers. EVs. Every megatrend needs power — and clean, baseload nuclear is the only source that scales.

Meanwhile, uranium production can’t keep up.

That’s why a tiny uranium explorer in the Athabasca Basin — home to the world’s highest-grade deposits — may soon be on every investor's radar.

Drill programs are planned. Momentum is building. And the market hasn’t caught up.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Beverages

Strong Demand and Higher Prices Lift Coca-Cola’s Q1 Results

Coca-Cola (NYSE: KO) reported first-quarter results today that are better than Wall Street's expectations, helped by price hikes and resilient demand for its beverages, including sodas and its Fairlife milk brand.

Shares are up about 1% in premarket trading following the announcement.

The beverage giant’s average selling prices climbed 5% during the quarter, while unit case volumes rose by 2%, signaling that customers remained willing to pay more despite broader concerns about inflation and a softer consumer spending environment.

In particular, Coca-Cola credited strength in high-inflation regions such as Argentina and other Latin American markets for driving pricing gains.

While major peers like PepsiCo and Procter & Gamble have reported weaker consumer demand trends, Coca-Cola saw continued momentum in North America, especially within its sparkling drinks and dairy offerings.

For the quarter, Coca-Cola posted a revenue of $11.22 billion, nearly flat compared to $11.23 billion a year earlier.

Analysts had anticipated a decline of 0.84% to $11.14 billion, meaning Coca-Cola managed to beat consensus forecasts.

Despite ongoing challenges from inflation and tariff-related pressures globally, Coca-Cola’s pricing power and brand strength have enabled it to maintain sales levels.

Investors will now be watching to see how the company navigates the rest of the year amid a still-uncertain macroeconomic backdrop.

Pharmaceuticals

Pfizer Tops Profit Forecasts on Strong Vyndaqel Sales and Cost Cuts

Pfizer (NYSE: PFE) reported first-quarter earnings today that are better than Wall Street projections, aided by aggressive cost-cutting efforts and strong sales of its heart disease treatment, Vyndaqel.

Adjusted earnings touched 92 cents per share, significantly higher than the 66 cents per share analysts had anticipated, according to LSEG data.

The pharmaceutical giant’s total revenue for the quarter is $13.70 billion, slightly trailing the consensus estimate of $13.91 billion.

Despite the revenue miss, shares of Pfizer are up about 1% in premarket trading, offering investors a positive start to the day after a challenging year that has seen the stock decline by over 13%.

Investors are keeping a close eye on the company's vaccine portfolio amid potential policy shifts under newly appointed U.S. health secretary Robert F. Kennedy Jr., known for his skepticism toward vaccines.

Any major changes could have significant implications for Pfizer’s vaccine-related earnings, particularly in a post-pandemic landscape.

Pfizer, along with other drugmakers, also faces the possibility of new tariffs on pharmaceutical imports, especially raw materials sourced from China — a key supplier for the industry. Rising costs from these duties could pressure margins if implemented.

As the company navigates these risks, Pfizer’s efforts to streamline operations and its continued momentum in specialized treatments like Vyndaqel are helping to stabilize performance in a turbulent healthcare market.

Uranium Bull Market (Sponsored)

On Behalf of Azincourt Energy Corp

In 2018, UEC was a forgotten uranium stock trading for just $0.60.

Five years later? It had exploded into a $3.11 billion juggernaut.

That’s the power of timing the uranium cycle.

But this time, the fuel behind it is different:

And right now, a tiny uranium explorer in Canada’s Athabasca Basin is sitting on drill-ready projects… just like UEC once was.

The opportunity is hiding in plain sight.

History doesn’t repeat, but in uranium… it often rhymes.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Streaming Music

Spotify Shares Slide After Weak Q2 User Forecast

Spotify (NYSE: SPOT) is seeing its shares fall more than 8% early Tuesday after issuing lower-than-expected guidance for second-quarter user growth and profitability.

The streaming giant now anticipates 689 million monthly active users (MAUs) for Q2, trailing the 694 million consensus.

For the first quarter, Spotify reported 678 million MAUs, a 10% increase from the previous year, but slightly below expectations.

Premium subscribers are up 12% year-over-year to 268 million, marking the second-highest Q1 net addition for the company.

Despite strong subscriber retention and engagement, CEO Daniel Ek acknowledged that near-term volatility may persist, while reaffirming confidence in Spotify's long-term growth trajectory.

Financially, Spotify posted Q1 gross margins of 31.6%, just above Wall Street's consensus but lower than its record 32.2% in the previous quarter.

The company’s second-quarter gross margin guidance of 31.5% slightly missed analysts’ estimates.

Analysts note that margin expansion may decelerate due to renegotiated contracts with major music labels.

Spotify shares had surged earlier this year, hitting all-time highs around $652 in February, driven by a company-wide restructuring, significant cost reductions, and expanded pricing tiers including audiobooks and bundled streaming plans.

However, concerns over macroeconomic uncertainty and slowing margin growth have recently weighed on sentiment.

Going forward, advertising revenue—which accounts for about 12% of total income—will be a key focus area amid broader market headwinds.

Movers and Shakers

Tevogen Bio Holdings Inc. [TVGN] - Last Close: $0.94

Tevogen Bio is a clinical-stage biotech company developing therapies for cancer and infectious diseases.

Its shares are up 14% in premarket trading after the company reaffirmed its ambitious revenue forecast for its oncology pipeline. Management projects $1 billion in revenue in the launch year and a cumulative $10–14 billion over five years.

My Take: Tevogen’s aggressive revenue targets are attention-grabbing, but without clinical data or FDA approvals, they remain speculative. Still, its a high-risk, high-reward biotech to watch.

Leggett & Platt, Incorporated [LEG] - Last Close: $7.27

Leggett & Platt is a diversified manufacturer known for its engineered components and products used in bedding, furniture, flooring, and automotive markets.

Its shares are rising sharply in premarket after the company posted Q1 adjusted earnings that exceeded Wall Street expectations. Earnings came in at $0.24 per diluted share, beating the consensus estimate of $0.22. More importantly, Leggett reaffirmed its full-year 2025 guidance, projecting $1.00–$1.20 per share in adjusted earnings and $4.0–$4.3 billion in revenue.

My Take: Leggett’s reaffirmation of guidance shows resilience despite soft demand. While revenue pressures linger, its strong dividend history and earnings stability could make LEG a solid hold for long-term, income-focused investors.

Beyond, Inc. [BYON] - Last Close: $4.18

Beyond is a digital retail company operating familiar brands like Bed Bath & Beyond, Overstock, and Zulily.

Its shares are surging 16% in premarket trade today after the company reported a much narrower Q1 loss than expected. The adjusted loss came in at $0.42 per share, significantly better than analysts’ estimate of a $0.65 loss.

My Take: Beyond’s aggressive restructuring appears to be paying off, but shrinking customer numbers remain a concern. Still, it could offer strong rebound potential from its heavily discounted levels, so keep an eye on this stock.

Uranium Supply Crunch (Sponsored)

On Behalf of Azincourt Energy Corp

Right now, the US has 94 nuclear reactors.

And 90% of the fuel they run on? It’s imported.

Tariffs are coming. Tensions are rising. And the government knows it needs more domestic-friendly supply.

Why Peter Thiel just joined the board of a uranium enrichment startup. Why Canada’s uranium is now more strategic than ever.

And why one tiny explorer in Saskatchewan’s Athabasca Basin could be positioned perfectly. The company has two active projects.

It’s drilling in the richest uranium district on Earth.

And as the US tries to secure its nuclear future, Canadian explorers like this one may be the first call utilities make.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.